Topics
CME/CE
Editorial Board
Perspectives: FDA Warning Against Renuvion/J-Plasma
In this video interview, Darren Smith, MD, comments on the Renuvion/J-Plasma device (Apyx Medical) receiving an FDA warning for dermal resurfacing or skin contraction. He dives into how the device may be causing these issues, how this affects patients, and more.
On March 14, the FDA released a warning for both consumers and health care providers against the use of the Renuvion/J-Plasma device (Apyx Medical) for dermal resurfacing or skin contraction. Watch the full video below for more perspective on this issue.
Related Content
